NCT06915727 2026-04-01
An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors
Mayo Clinic
Phase 3 Recruiting
Clinical Trials
11 trialsNCT06511037 2026-02-27
PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis
University of California, Irvine
Phase EARLY_PHASE1 Recruiting
NCT07278986 2025-12-12
CYTALUX ISS
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Recruiting
NCT06434909 2025-10-21
CYTALUXâ„¢for the Intraoperative Imaging of Prostate Cancer
Indiana University
Phase 2 Completed
NCT07039526 2025-09-24
Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.
University of Texas Southwestern Medical Center
Phase 2 Recruiting
NCT07124351 2025-09-15
Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUXâ„¢)
Cedars-Sinai Medical Center
Phase 4 Recruiting
NCT06235125 2024-08-22
Cytalux
Ann & Robert H Lurie Children's Hospital of Chicago
Phase 1 Recruiting
NCT02602119 2022-06-28
Intraoperative Imaging of Pulmonary Nodules by OTL38
University of Pennsylvania
Phase 1 Completed
NCT04941378 2022-06-27
OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian Cancer
Abramson Cancer Center at Penn Medicine
Phase 1 Withdrawn
NCT02645409 2020-02-25
Intraoperative Folate Targeted Fluorescence in Renal Cell Carcinoma
Indiana University
Phase NA Completed
NCT02629549 2019-08-06
Intraoperative Imaging of Pituitary Adenomas by OTL
University of Pennsylvania
Phase 1 Terminated